Home/Search
2025 Scientific Sessions
Structural Heart Disease
Breakfast Program: Radiation and Orthopedic Safety in the Cath Lab—We Can Do Both (CME)
Welcome and Overview
Allison G. Dupont, M.D., FSCAI
Scope of the Problem and What SCAI's Doing About It
James B. Hermiller, M.D., MSCAI
What’s in the Toolkit? Radiation Reduction, Shielding Tools, and Advanced Imaging Techniques
Arnold H. Seto, MD, MPA, FSCAI
The Economic Argument: How to Influence Administration to Invest in the Health of Cath Lab Workers
Anna Bortnick, M.D., Ph.D., FSCAI
Practical Considerations for Implementation: Cath Lab Director's Perspective
Islam Abudayyeh, M.D., FSCAI
Breakfast Program: Tricuspid TEER—Mastering the Technique (CME)
Welcome and Overview
Jason H. Rogers, M.D., FSCAI
Clinical Case Example: Severe TR
Anene Ukaigwe, M.D., FSCAI
Patient Selection for Tricuspid TEER
Chad Kliger, M.D., FSCAI
Procedural Strategy and Planning for Tricuspid TEER
Paul Dennis Mahoney, M.D., FSCAI
Challenging Imaging: When to Consider 3D ICE
Gagan Singh, M.D., FSCAI
T-TEER and Device Leads: How to Manage
Anita W. Asgar, M.D., FSCAI
Case Resolution
Anene Ukaigwe, M.D., FSCAI
Deep Dive: Mastering Mitral TEER
COAPT and Beyond: Patient Selection and Periprocedural Optimization
Anene Ukaigwe, M.D., FSCAI
M-TEER Device Landscape
Sammy Elmariah, M.D., FSCAI
The Key to Success: Intraprocedural Imaging and Guidance of M-TEER
Geraldine Ong
Case #1: Primary MR
Dr. Giorgio A. Medranda, MD, FSCAI
Case #1: Resolution
Dr. Giorgio A. Medranda, MD, FSCAI
Case #2: Mixed DMR-FMR
Marwan S Saad, MD, PhD, FSCAI
Case #3: Atrial FMR
Michael N. Young, MD, FSCAI
Case #3: Resolution
Michael N. Young, MD, FSCAI
Intraprocedural Evaluation and Predictors of Outcomes: What Defines Procedural Success?
George S. Hanzel, M.D., FSCAI
Fundamentals and General Overview of Transcatheter Mitral Interventions
Everything You Need to Know About the Mitral Valve for Transcatheter Therapies
Anita W. Asgar, M.D., FSCAI
Echo of the Mitral Valve: A Primer for the Interventional Cardiologist
Geraldine Ong
Green, Yellow, Red: How Do I Select the Best Patient for Transcatheter Therapies?
Anu Tunuguntla, M.D., FSCAI
Transcatheter Edge to Edge: Present and Future
Santiago Garcia, MD, FSCAI
Beyond TEER: What Can We Offer a Red Zone Patient?
Homam Ibrahim, M.D., FSCAI
Tips and Tricks of Mitral Valve-in-Valve Procedure
Christine J. Chung, M.D., FSCAI
Future Perspectives in the Mitral Space: Which Trials and What Devices Are We Missing?
Paul Fiorilli, M.D., FSCAI
Hildner Lecture
Competition vs. Compassion: What Leads to Innovation and Self-Improvement?
Bill L. Lombardi, M.D., FSCAI
Innovation or Complication? Exploring the Impact of Percutaneous Pulmonary Valves
Debate: Asymptomatic Patient (<12 y.o., Meeting Current Indications for Valve Placement for PR) GO!
Shabana Shahanavaz, M.B.B.S.
Debate: Asymptomatic Patient (<12 y.o., Meeting Current Indications for Valve Placement for PR) WAIT!
Bryan H. Goldstein, M.D., FSCAI
Head to Head: Percutaneous and Surgical Valve Interventions Compared
Laith Alshawabkeh
Complications of Self-Expanding Valves
Doff B. McElhinney, M.D., FSCAI
Keynote Presentation: Brief Glimpse at the Past and Hopes for the Future of Interventional Cardiology
Introductory Remarks: Keynote Speaker
Binita Shah, M.D., M.S., FSCAI
Keynote Presentation: Brief Glimpse at the Past and Hopes for the Future of Interventional Cardiology
Robert Califf, M.D.
Lessons From the Trenches: Real-World Challenges in Heart/Brain Interventions
New! SCAI/HRS LAAO Guidelines
Dr. Andrew Michael Goldsweig, MD, MS, FSCAI
Seeing Is Believing. CTA vs. TEE vs. ICE for LAAO and PFO
Omar Khalique, M.D., FSCAI
Embolization Escapades: Securing the Unsecured
John M. Lasala, M.D., Ph.D., MSCAI
Perforation Perils: Is LAAO Still a Risk?
Himanshu Agarwal, M.D., FSCAI
Sealing the Deal: Mastering Residual Leak Management
Saibal Kar, M.D., FSCAI
Different Faces of PFOs: They Are Not All the Same
Zahid C. Amin, M.D., MSCAI
Let’s Take the Gloves Off: Controversies in Structural Heart Care
Debate! Tricuspid Interventions Showdown: Why Replace What You Can Repair?
Mackram F. Eleid, M.D., FSCAI
Debate! Tricuspid Interventions Showdown: Why Replacement Outshines Repair
Santiago Garcia, MD, FSCAI
Risky Business: Is TAVR the Right Call for the Under 65 Crowd?
Ranya Sweis, M.D., FSCAI
Universal Solution or Therapeutic Overreach? Should LAAO Be the Default Approach for Stroke Prevention in All Atrial Fibrillation Patients?
Karim Al-Azizi, M.D., FSCAI
Stop Kidding Me! When Is Old Really Too Old?
Megan Coylewright, M.D., FSCAI
Pricey Progress: Are SHD Innovations Breaking the Bank?
Michael J. Rinaldi, M.D., FSCAI
Lunch Program: The Case for Early Treatment in Severe Aortic Stenosis (SAS) Patients—What the Latest Evidence Tells Us (CME)
Welcome and Introductions
James B. Hermiller, M.D., MSCAI
Patient Pathway Solutions: Results of the DETECT-AS Study
Sammy Elmariah, M.D., FSCAI
Latest Evidence from the EARLY TAVR Trial: Treatment of Asymptomatic SAS Patients
Philippe Genereux MD, M.D.
Heart Teams and Referrers: How Can They Engage to Treat All SAS Patients and Address Capacity?
David J. Cohen, M.D., FSCAI
TAVR in Younger Patients: What About Durability?
Megan Coylewright, M.D., FSCAI
Panel Discussion: How Will Your Practice Change?
Molly Szerlip, M.D., FSCAI
Navigating Tricuspid Regurgitation: From Imaging to Interventions
Decoding Tricuspid Regurgitation: Anatomy, Physiology, and the Things That Matter
Roosha Parikh, MD, FSCAI
Focused Insights: Guiding Interventions From Start to Finish
Geraldine Ong
Tailored Tricuspid Treatments: How to Decide on Surgery vs. T-TEER vs. TTVR
Amar Krishnaswamy, M.D.
T-TEER Case: What Does Success Look Like?
Edwin Ho
TTVR Case: Essential Elements for Great Outcomes
Dr. Andrea Scotti, MD
The Art of the Save: Managing Complications of Tricuspid Intervention
Sammy Elmariah, M.D., FSCAI
Presidential Address by James Hermiller, MD, MSCAI, President 2024-2025, Award Presentations
Presidential Address by James Hermiller, MD, MSCAI
James B. Hermiller, M.D., MSCAI
SCAI Award Presentation: Mason Sones Distinguished Service Award
James B. Hermiller, M.D., MSCAI
Revisiting the Art of VSD Closure
Anatomical Prerequisites for Perimembranous VSD Closure From an Interventionalist Perspective
Nageswar Rao Koneti, MD
Currently Available Devices for VSD Closure
Makram R. Ebeid, M.D., FSCAI
Perventricular VSD Closure
Gareth J. Morgan, M.B.B.S., FSCAI
Creation of VSD Indication and Technique
David T. Balzer, M.D., MSCAI
Post-MI VSD Closure
John M. Lasala, M.D., Ph.D., MSCAI
SCAI WIN: Coronary and Structural Case Presentations with Expert Debates on Treatment Strategies
Coronary Case Presentation
Mariem Sawan, MD
Debate: Complete Revascularization – Pro
Saba Z Assar, MD
Debate: Complete Revascularization – Con
Allison Barbara Hall, M.D., FSCAI
Structural Case Presentation
Ranya Sweis, M.D., FSCAI
Debate: Tricuspid Regurgitation – Repair
Anita W. Asgar, M.D., FSCAI
Debate: Tricuspid Regurgitation – Replace
Megan Coylewright, M.D., FSCAI
Structural Heart: Year in Review
Year in Review: Aortic Valve Therapies
Aaron Horne Jr., M.D.
Year in Review: Mitral Valve Therapies
Matthew W. Sherwood, M.D., FSCAI
Year in Review: Tricuspid Valve Therapies
Georges Ephrem, M.D., FSCAI
Year in Review: Left Atrial Appendage Occlusion (LAAO) and Stroke Prevention
Jacqueline Saw, M.D., FSCAI
TAVR Complex Techniques
State of the Art: Valve-in-Valve TAVR and TAVR in TAVR
Grant William Reed, MD, MSc, FSCAI
Transcatheter Electrosurgery and Aortic Leaflet Modification: Basilica, Telltale, Shortcut, and Cleve/Unicorn
Isida Byku, M.D.
TAVR and LVOT Obstruction
Toby Rogers, MD, PhD
Managing PVL
Atman P. Shah, M.D., FSCAI
Upstream TAVR
Philippe Genereux MD, M.D.
TAVR for Aortic Insufficiency
Santiago Garcia, MD, FSCAI
Surgical Innovations When TAVR Isn’t an Option and When TAVRs Fail
Matthew Cavender, M.D.
TAVR Fundamentals: From Hemodynamics to New Innovations
Complex Hemodynamics of Aortic Stenosis
Nils P Johnson, M.D.
Patient Prosthesis Mismatch and TAVR in Small Annuli
Karim Al-Azizi, M.D., FSCAI
Bicuspid TAVR Considerations
Amar Krishnaswamy, M.D.
Lifetime Management: TAVR in the Young Patient
Matthew Cavender, M.D.
TAVR Access in 2025
Noa Holoshitz, M.D., FSCAI
What’s New: Recent TAVR Trials
Howard C. Herrmann, M.D., MSCAI
Valve Techniques: Beyond Pulmonary Valves
TAVR in Congenital Heart Disease...Really?
Athar M. Qureshi, M.D., FSCAI, FSCAI
Opening New Pathways: How Tricuspid Valve Interventions Aid CHD Patients
Azeem Latib, M.D.
AV Valve Intervention in Complex Congenital Heart Disease
Laith Alshawabkeh
Mitral Valve Intervention in CHD: Clips
Laith Alshawabkeh
Mitral Valve Intervention in CHD: Valve in Valve and Valve in Ring
Daniel S. Levi, M.D., FSCAI
Welcome by Program Chair Binita Shah, MD, FSCAI
Welcome by Program Chair Binita Shah, MD, FSCAI
Binita Shah, M.D., M.S., FSCAI